Venous thromboembolism is a major cause of morbidity and mortality in the health system, and all patients should be assessed to determine their level of risk. The latest prophylactic treatment guidelines are presented here.
Cindy Le, PharmD
Advertisement
Articles by Cindy Le, PharmD
Advertisement
Latest Updated Articles
- Roundup: Formulary Considerations for VTE
August 1st 2008
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5